Haemonetics Corporation HAE
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 19.70% | -3.00% | -134.75% | 19.33% | 14.34% |
| Total Depreciation and Amortization | -1.75% | -5.73% | -1.34% | -5.65% | -3.29% |
| Total Amortization of Deferred Charges | -- | -- | -8.96% | -- | -- |
| Total Other Non-Cash Items | -12.78% | 21.00% | 848.05% | -23.38% | 39.22% |
| Change in Net Operating Assets | 45.96% | 63.95% | -115.29% | 133.43% | 195.34% |
| Cash from Operations | 15.07% | 200.79% | -39.14% | 113.78% | 128.01% |
| Capital Expenditure | -194.48% | -110.60% | -12.90% | 25.71% | 46.82% |
| Sale of Property, Plant, and Equipment | 380.00% | -20.20% | -78.54% | 72.11% | -36.51% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.53% | 50.70% | 22.90% | -159.46% | -106.76% |
| Cash from Investing | 20.29% | 32.62% | -580.12% | -69.63% | -30.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,201.02% | -3,198.98% | -19,193.79% | -0.06% | -- |
| Issuance of Common Stock | 2,996.83% | -9.88% | -12.86% | 6.50% | -74.90% |
| Repurchase of Common Stock | 99.48% | 26.79% | 33.30% | 64.37% | 0.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -45,058.97% | 61.11% | 51.85% | 90.60% | -254.55% |
| Cash from Financing | 11.68% | -2,010.07% | 32.98% | 47.32% | -2.34% |
| Foreign Exchange rate Adjustments | 245.67% | -114.75% | -127.29% | 113.04% | -118.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 958.05% | -59.08% | -737.37% | 210.44% | 107.81% |